Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond

Sebastien Foulquier; U. Muscha Steckelings; Thomas Unger

doi:10.1007/s11906-012-0291-6

Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond

Sebastien Foulquier, U. Muscha Steckelings, Thomas Unger^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

52 Downloads (Pure)

Abstract

It is now widely accepted that the angiotensin AT(2) receptor (AT(2)R) plays an important protective role during pathophysiologic conditions, acting as a repair system. The development of the first selective nonpeptide AT(2)R agonist C21 accelerated our understanding of AT(2)R-mediated protective signaling and actions. This article reviews the impact of C21 on blood pressure in normotensive and hypertensive animal models. Although C21 does not act as a classical antihypertensive drug, it could be useful in preventing hypertension-induced vascular and other end organ damages via anti-apoptotic, anti-fibrotic and anti-inflammatory actions. In particular, a strong body of evidence started to emerge around its anti-inflammatory feature. This property should be further investigated for potential clinical indications in cardiovascular diseases and beyond.

Original language	English
Pages (from-to)	403-409
Journal	Current Hypertension Reports
Volume	14
Issue number	5
DOIs	https://doi.org/10.1007/s11906-012-0291-6
Publication status	Published - Oct 2012

Keywords

Hypertension
Blood pressure
Angiotensin
AT(2)R
Renin-angiotensin system
RAS
Compound 21
C21
Inflammation
Antihypertensive drug therapy

Access to Document

10.1007/s11906-012-0291-6

Full TextFinal published version, 199 KBLicence: Taverne

Cite this

@article{a0255fbc220b4b33ab535e8954d6584e,

title = "Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond",

abstract = "It is now widely accepted that the angiotensin AT(2) receptor (AT(2)R) plays an important protective role during pathophysiologic conditions, acting as a repair system. The development of the first selective nonpeptide AT(2)R agonist C21 accelerated our understanding of AT(2)R-mediated protective signaling and actions. This article reviews the impact of C21 on blood pressure in normotensive and hypertensive animal models. Although C21 does not act as a classical antihypertensive drug, it could be useful in preventing hypertension-induced vascular and other end organ damages via anti-apoptotic, anti-fibrotic and anti-inflammatory actions. In particular, a strong body of evidence started to emerge around its anti-inflammatory feature. This property should be further investigated for potential clinical indications in cardiovascular diseases and beyond.",

keywords = "Hypertension, Blood pressure, Angiotensin, AT(2)R, Renin-angiotensin system, RAS, Compound 21, C21, Inflammation, Antihypertensive drug therapy",

author = "Sebastien Foulquier and Steckelings, {U. Muscha} and Thomas Unger",

year = "2012",

month = oct,

doi = "10.1007/s11906-012-0291-6",

language = "English",

volume = "14",

pages = "403--409",

journal = "Current Hypertension Reports",

issn = "1522-6417",

publisher = "Current Medicine Group",

number = "5",

}

TY - JOUR

T1 - Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond

AU - Foulquier, Sebastien

AU - Steckelings, U. Muscha

AU - Unger, Thomas

PY - 2012/10

Y1 - 2012/10

N2 - It is now widely accepted that the angiotensin AT(2) receptor (AT(2)R) plays an important protective role during pathophysiologic conditions, acting as a repair system. The development of the first selective nonpeptide AT(2)R agonist C21 accelerated our understanding of AT(2)R-mediated protective signaling and actions. This article reviews the impact of C21 on blood pressure in normotensive and hypertensive animal models. Although C21 does not act as a classical antihypertensive drug, it could be useful in preventing hypertension-induced vascular and other end organ damages via anti-apoptotic, anti-fibrotic and anti-inflammatory actions. In particular, a strong body of evidence started to emerge around its anti-inflammatory feature. This property should be further investigated for potential clinical indications in cardiovascular diseases and beyond.

AB - It is now widely accepted that the angiotensin AT(2) receptor (AT(2)R) plays an important protective role during pathophysiologic conditions, acting as a repair system. The development of the first selective nonpeptide AT(2)R agonist C21 accelerated our understanding of AT(2)R-mediated protective signaling and actions. This article reviews the impact of C21 on blood pressure in normotensive and hypertensive animal models. Although C21 does not act as a classical antihypertensive drug, it could be useful in preventing hypertension-induced vascular and other end organ damages via anti-apoptotic, anti-fibrotic and anti-inflammatory actions. In particular, a strong body of evidence started to emerge around its anti-inflammatory feature. This property should be further investigated for potential clinical indications in cardiovascular diseases and beyond.

KW - Hypertension

KW - Blood pressure

KW - Angiotensin

KW - AT(2)R

KW - Renin-angiotensin system

KW - RAS

KW - Compound 21

KW - C21

KW - Inflammation

KW - Antihypertensive drug therapy

U2 - 10.1007/s11906-012-0291-6

DO - 10.1007/s11906-012-0291-6

M3 - Article

C2 - 22836386

SN - 1522-6417

VL - 14

SP - 403

EP - 409

JO - Current Hypertension Reports

JF - Current Hypertension Reports

IS - 5

ER -